Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results: 1-10 of 40,804

IPBC Europe

Patents in France

Casalonga & Associés
France, Global
September 22 2017

A structured guide to patents law and practice in France

Inutility finding overturned by Federal Court of Appeal in first application of Supreme Court’s Esomeprazole decision

Gowling WLG
Canada
September 22 2017

The Federal Court of Appeal's (FCA) first application of the Supreme Court of Canada's (SCC) decision in AstraZeneca Canada v Apotex

Federal Circuit Clarifies Venue Law in the Wake of TC Heartland

Morgan Lewis & Bockius LLP
USA
September 22 2017

On September 21, the US Court of Appeals for the Federal Circuit issued an opinion in In re: Cray Inc. clarifying how district courts should determine

Third-Party Submissions Under 35 USC 122(e)

Workman Nydegger
USA
September 22 2017

Many companies track new patent applications that publish within the fields that they operate in, in order to keep abreast of what their competitors

Introduction to Macau and its Intellectual Property System

BN Lawyers
Macau
September 22 2017

Macau is one of two Special Administrative Regions of the People's Republic of China, the other being Hong Kong. Until 1999 it was a territory under

Patent enforcement through the courts in France

Casalonga & Associés
France, Global
September 22 2017

A structured guide to enforcing patents through the courts in France

Production of Documents from the United States for Use in Australian Patent Litigation

Spruson & Ferguson
Australia, USA
September 22 2017

In the United States discovery of documents for use in proceedings outside the U.S. is articulated in Title 28 of the Code of Laws of the

Patentability in France

Casalonga & Associés
France, Global
September 22 2017

An overview of patentability in France

Federal Court of Canada Rejects NIAs, and Strikes S. 8 Damages in LOSEC (omeprazole) Patent Infringement Damages Decision

McCarthy Tétrault LLP
Canada
September 21 2017

In AstraZeneca v Apotex, 2017 FC 726, the Federal Court issued its damages decision concerning Apotex’s infringement of a patent pertaining to

Current Search

Refine

Content type

Tags